Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

SARS-CoV-2 Detection in Fecal Samples in Sym-asymptotic Patients with Typical Findings of COVID-19 on Ag-RDT and SARS-CoV-2 RT-PCR Tests

Version 1 : Received: 27 September 2022 / Approved: 28 September 2022 / Online: 28 September 2022 (11:51:21 CEST)

How to cite: Magwanga, R.O.; Onyango, B.; Ochieng, A.; Awandu, S.S.; Were, P.; Kirungu, J.N.; Oloo, M.A.; Muok, E.; Munga, S.; Ogutu, F.; Orwa, A.; Okumu, F.; Onyango, C.; Awuor, D.; Orata, F.; Ochieng’-Midega, J.; Oure, B.; Nyunja, R.; Ade, F.; Indechi, S.; Okuto, E.; Estambale, B. SARS-CoV-2 Detection in Fecal Samples in Sym-asymptotic Patients with Typical Findings of COVID-19 on Ag-RDT and SARS-CoV-2 RT-PCR Tests. Preprints 2022, 2022090439. https://doi.org/10.20944/preprints202209.0439.v1 Magwanga, R.O.; Onyango, B.; Ochieng, A.; Awandu, S.S.; Were, P.; Kirungu, J.N.; Oloo, M.A.; Muok, E.; Munga, S.; Ogutu, F.; Orwa, A.; Okumu, F.; Onyango, C.; Awuor, D.; Orata, F.; Ochieng’-Midega, J.; Oure, B.; Nyunja, R.; Ade, F.; Indechi, S.; Okuto, E.; Estambale, B. SARS-CoV-2 Detection in Fecal Samples in Sym-asymptotic Patients with Typical Findings of COVID-19 on Ag-RDT and SARS-CoV-2 RT-PCR Tests. Preprints 2022, 2022090439. https://doi.org/10.20944/preprints202209.0439.v1

Abstract

Coronavirus is a disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged as a global pandemic in 2019 from Wuhan, China. Since its emergence, it has caused immense suffering to human life, 6.27 million lives have been lost, movement curtailed and social dynamics disrupted. The golden standard for getting samples for SARS-CoV-2 detection is through oral- nasopharyngeal swab, this method of sample collection is invasive and uncomfortable, thus stigmatized the general population, and thereby impeded the progress of controlling the spread through mass testing. Being a contact disease, mechanisms to encourage mass testing is key to reduce the spread. This study thus developed a complimentary sample type to test for SARS-CoV-2, the use of human feces. Fecal samples were collected from 100 asym-symptomatic individuals suspected to be infected with COVID-19, virus RNA was then extracted and profiled through Real Time Polymerase Chain Reaction (RT-qPCR). The antigen rapid diagnostic test revealed high positivity rate of 44%, but the real time polymerase chain reaction results on nasopharyngeal and fecal samples revealed a significant variation, high number of the patients tested positive with stool samples compared to the nasopharyngeal swabs, with 43 and 37%, respectively. SARS-CoV-2 virus was detected in both symptomatic and asymptomatic individuals; however, the symptomatic registered a higher positivity of 25% compared to 20% among the asymptomatic patients. Vaccination only lowered the risk of infection, fully and partially vaccinated lowered the infection level to 10% compared to 20% among the unvaccinated. Finally, gender parity in relation to COVID19 was evaluated, more females (56%) compared to males were recruited in this study, out of which (20; 43.4%) were positive, and 26 (56.6%) were negative based on fecal RT-qPCR outcomes. Based on the outcome of this study, rapid diagnostic test (Ag-RDT) however cheap and or fast does not provide accurate information, moreover, the virus does not stay longer within the Oro-nasopharyngeal region, thus the invalid or negative results, thus use of feces should be adopted as a confirmatory test to ascertain the COVID19 status of an individual.

Keywords

COVID19; SARS-CoV-2 virus; Oro-nasopharyngeal; fecal; vaccination; asym-symptomatic; rapid diagnostic test

Subject

Medicine and Pharmacology, Pathology and Pathobiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.